2011-2012: JSPS Postdoctoral fellows at Laboratory of Molecular Medicine, Institute of Medical Science, The University of Tokyo and visiting researcher for the Division of Genetics, National Cancer Center Research Institute, Japan.
2012-2014: Research Scientist at Laboratory for Statistical Analysis, Center for Integrative Medical Sciences, The Institute of Physical and Chemical Research (RIKEN), Japan.
2015-2016: Lecturer at Faculty of Pharmacy, University of Sydney, Australia.
2017-Current: Group leader for Cancer Neoantigen Vaccine Development Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (JFCR).
Siew-Kee (Amanda) Low has been working extensively in genomic research that expands from cancer genomics, pharmacogenomics and various genomic studies for complex diseases. During her Ph.D. and postdoctoral fellows, she has performed comprehensive genomic analysis by utilizing large-scale genome-wide association studies (GWAS) and whole genome/exome studies to identify genetic variations associated with various complex diseases and pharmacogenomics studies. She is also the lead biostatistician representing Biobank Japan participating various international consortium. She has published in top-notch journals such as Nature Genetics, PNAS, Human Molecular genetics and etc.
Currently, she is establishing the liquid biopsy system for cancer suivellance and monitoring in JFCR. As part of the Japan national project "Innovative AI hospital system", she is one of the leaders to standardize and implement liquid biopsy in the medical system in Japan.